From the first launch to ongoing market access operational execution, IntegriChain solves some of the most complex and pressing challenges associated with drug commercialization. We deliver pharma’s only comprehensive data, consulting, and business process platform for market access departments, providing the strategy, data, applications, and infrastructure for therapy commercialization.
Solutions overview
IntegriChain delivers the pharmaceutical industry’s largest and only data and business process platform for therapy commercialization and access. Manufacturers rely on our analytics, applications, and managed services to power their operations and harness the value of their channel, patient and payer data.
View all products
IntegriChain provides a complete set of professional services for commercialization and market access execution–from life science strategy and operational consulting to implementation, integration, migrations, and analytics.
Services overview
We help all stakeholders in the pharmaceutical industry drive access with our relentless focus on unifying all of the critical business functions for therapy commercialization and access – contracts & pricing, gross-to-net, channel, and patient services – to unlock strategic payer, provider, pharmacy and patient access insights.
Learn more about our company
Learn more about joining our growing IntegriChain team of data scientists, market access experts, analysts, and consulting professionals – our culture, our purpose, our teams in the US and Pune. Check out our careers or keep in touch for future opportunities.
Careers overview
Pandemic travel and gathering restrictions put a damper on many conferences. But due to popular demand, we are transitioning our annual conference to an Access Insights Virtual Summit. Join us for a short series of insightful sessions by our subject matter experts on today’s market access challenges and how we’re addressing those challenges with our vision and exciting innovation.
Tuesday, October 20
Wednesday, October 21
Thursday, October 22
Joshua Halpern
Co-Founder and EVP, Product & Strategy
Strategic Business Case for a Unified Data and Business Process Platform for Market Access
10-10:45 am ET
Traditionally, market access teams have faced significant challenges due to barriers created by limited data access in revenue management, data fragmentation, and underserved analytics consumers. In this session, we’ll review several case studies of manufacturers that have unified their market access data and operations to make smarter contract and pricing decisions, solve patient access barriers, and achieve better GTN predictability.
Request the Recording of this Session
Dharma Subramanian
VP, Data Products and ICyte Analytics
Brian Coleman
Executive Director, Product Management – Applications
Co-Founder and EVP, Product and Strategy
The Vision for the Unified ICyte Platform
11:15-noon ET
In this session, we will review our vision for the ICyte Platform that powers the business vision we shared in the first session of the day. ICyte is the industry’s first unified market access platform for channel, contracts and pricing, patient access, and GTN data, analytics, and applications–all supported by a value-boosting platform of services. In this unified platform, shared master data drives all ICyte applications, analytics, and services, delivering complete and comprehensive market access insights and key performance indicators to drive your access strategy, day-to-day decision-making, and shared vision for your market access, finance, and executive stakeholders. We’ll outline our plan and progress to date for delivering a fully unified market access ICyte Platform.
Ushank Agarwal
Senior Director, Commercial Analytics, Immunomedics
Case Study: How Immunomedics Leveraged IntegriChain’s Refined Channel and CRM Data for a Successful Specialty Launch
Siloed channel and market access data — combined with disconnected master data across the commercial systems landscape — creates a number of obstacles to a successful product launch and proactive engagement for both buy-and-bill and “specialty light” products. In this session, we’ll examine how Immunomedics implemented commercial analytics to support TrodelvyTM including territory performance reporting, incentive compensation, and enhanced targeting. We’ll also examine how to utilize unblinded 867 data as a foundational asset, and integrate it with the Veeva commercial data warehouse and CRM solution to improve visibility and value.
Watch the Recording
Sean McCarthy
Segment Leader, Patient Access
Lucas Dan
Director, Data Science
New Advances in Patient Data Stewardship and Patient Services Analytics
In this session, our patient access and data sciences experts will deliver a deep dive on our summer release focused on improving patient data quality. We’ll examine innovative approaches to identifying data timeliness, granularity, and accuracy issues that enable manufacturers to rapidly communicate, triage, and resolve issues with specialty pharmacies in their networks.
Sean Downey
SVP Managed Services
Jeff Tanner
VP, Systems Integration Delivery
An Agile Market Access Business: Implementing Large-Scale Managed Services
Mid-market and large Life Sciences enterprises share a common vision for their technology and commercial insights roadmaps to achieve operational excellence. In this session, we examine the strategic business case for transitioning aging on-premises revenue management to the cloud for best-of-breed pricing and adjudication engines combined with proprietary technologies such as claim-level detail, payment portals, and OCR. We’ll also cover how operations of scale can achieve the economic benefits of outsourcing non-strategic market access operations, digitalizing GTN forecasting and accruals, and shifting the best talent to market access business insights. We’ll review how leading manufacturers are making this transition—their vision, where they are in the process, and key lessons learned along the way.
Jen Sharpe
Executive Director, Gross-to-Net
Jon Brier
Director, Product Management
Dan Lacasse
Director, Managed Services
GTN Product Roadmap and Recent Releases
GTN automation, the most critical financial challenge for Life Sciences manufacturers, can improve margins, reduce costs, and mitigate risk by delivering one accurate version of the GTN truth throughout your organization. In this session, we will introduce our newest product and the first major step in our roadmap to a unified ICyte Analytics: GTN Analytics. GTN Analytics delivers critical analytics, trends, and metrics, allowing you deeper insights and more predictability for a complete, data-driven, and unified view of forecasting and accruals throughout your organization. We’ll also review our vision and product roadmap for our GTN offerings, including improved customer flexibility, an expanded methodology library, new demand sales forecasting, additional closing flexibility, and enhanced user-friendliness.
